Isomerase is delighted to announce that they will be one of the sponsors for Directed Biosynthesis VII. Established in 2006, and now in its seventh iteration, Directing Biosynthesis is a key conference for the community of researchers interested in diverse aspects of biosynthesis.

As in the past, this conference will bring together established researchers, early-career scientists, post-graduate students and members of industry to share and discover cutting-edge research, reconnect with colleagues and establish new collaborations. Ample opportunities will be provided for both networking and discussion, as well as for poster presentations by younger researchers.

Themes this year will include:

• Genetics, enzymology and structural biology of natural product biosynthesis
• Genome and microbiome mining, microbiome engineering
• Synthetic biology and metabolic engineering
• Chemical ecology and computational approaches for assessing natural products/enzyme functional diversity
• Industrial applications of natural products and biosynthetic enzymes

Staff from isomerase will be in attendance if you have any questions for us. Please feel free to either visit our table, or to contact us via the website or This email address is being protected from spambots. You need JavaScript enabled to view it. in advance to arrange a meeting.
For more information about Isomerase, please visit www.isomerase.com

About Isomerase

Isomerase is a leading innovation partner for all aspects of microbial product and process discovery and development, including leading-edge synthetic biology, advanced strain improvement of microorganisms, genome sequence analysis, protein and peptide expression and isolation, fermentation and process development, DSP, compound isolation, analytical development and synthetic chemistry. In addition, Isomerase manages other aspects necessary for a commercially successful programme on behalf of partners, such as compound management and shipping and scaled manufacture.

We offer these capabilities underpinned by a portfolio of technology IP, and the combined experience of a core technical and leadership team with a substantive track record of successful product discovery and development collaborations with pharma and biotech companies.

We have supported numerous companies with a wide variety of microbial product and small molecule fermentation and synthetic chemistry projects, helping advance early-stage concepts into valuable development programmes, and then continuing to support their progress to market with process improvement and scaled manufacture.

For more information please contact Isomerase via our contact page.

Save
Cookies user preferences
All essential cookies are mandatory in order to allow logging in and submitting forms etc. You can choose to decline some non-essential ones.
Accept all
Decline all
Read more
Analytics
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Analytics
Accept
Decline